1789P Second OS interim analysis from BEAT-SC: A randomized phase III study of bevacizumab (bev) or placebo in combination with atezolizumab and platinum-based chemotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC).

Authors :: Han, B.
Ohe, Y.
Nishio, M.
Watanabe, S.
Ren, X.
Murakami, S.
Yang, N.
Okamoto, I.
Li, G.
Katakami, N.
Liu, X.
Hamaguchi, N.
Nakagawa, Y.
Hayashi, M.
Nanki, T.
Qian, C.
Yamamoto, N.
Source :: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1063-S1064. 2p.
Publication Year :: 2024

Subjects :: *SMALL cell lung cancer
*ATEZOLIZUMAB
*BEVACIZUMAB
*PLACEBOS
*CANCER chemotherapy

Full Text Access

Tools